Down-regulation of Interferon signature in systemic lupus erythematosus patients by active immunization with Interferon alpha-Kinoid
IFN-K or placebo was administered at day 0, day 7, day 28 in all patients. Half the subjects received a fourth injection at day 84 (see treatment protocol)
- Primary Purpose
- -
- Description of Cohorts
- -
- Informed Consent Given?
- -
- Multi-center Study?
- -
- Organisms
- Homo sapiens
- Number of subjects
- -
- Diseases
- systemic lupus erythematosus
- Sample Sources
- -
- Type of Samples Collected
- -
